Elevated CD86 and HLA-DQ expression in CD11c+ MoDCs to PTG exposure highlights the hypersensitivity of CeD patients to this stimulant in contrast to the general homeostatic response. This evidence concerns the gene ITGAX and cranioectodermal dysplasia.